We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Trial Conduct Violations Lead to Warning Letter for Anulex
Trial Conduct Violations Lead to Warning Letter for Anulex
February 25, 2011
The FDA has warned Anulex Technologies for conducting a clinical trial for its Xclose anular repair device without an approved investigational device exemption (IDE) or adequate investigator agreements.